share_log

Illumina | 8-K: Current report

Illumina | 8-K: Current report

Illumina | 8-K：重大事件
美股SEC公告 ·  11/04 16:12

Moomoo AI 已提取核心訊息

Illumina, Inc., a global leader in DNA sequencing and array-based technologies, reported its financial results for the third quarter ended September 29, 2024, on November 4, 2024. The company announced a slight decrease in Core Illumina revenue to $1.1 billion for Q3 2024, a 2% drop from Q3 2023. Despite the revenue decline, Illumina experienced a significant increase in GAAP operating margin to 68.6% and a non-GAAP operating margin of 22.6% for the same period. The GAAP diluted EPS was $4.03, and non-GAAP diluted EPS was $1.14 for Q3 2024. Illumina also adjusted its fiscal year 2024 guidance, expecting a revenue decline of approximately 3% from the previous year but raised its non-GAAP operating margin guidance to a range of 21% to 21.5% and non-GAAP diluted EPS guidance to $4.05 to $4.15. The company's financial outlook was revised due to the constrained macroeconomic environment, although the demand for Illumina's products remains strong. The company's press release also highlighted the spin-off of GRAIL on June 24, 2024, and several strategic initiatives and product launches aimed at accelerating revenue growth and margin expansion.
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, reported its financial results for the third quarter ended September 29, 2024, on November 4, 2024. The company announced a slight decrease in Core Illumina revenue to $1.1 billion for Q3 2024, a 2% drop from Q3 2023. Despite the revenue decline, Illumina experienced a significant increase in GAAP operating margin to 68.6% and a non-GAAP operating margin of 22.6% for the same period. The GAAP diluted EPS was $4.03, and non-GAAP diluted EPS was $1.14 for Q3 2024. Illumina also adjusted its fiscal year 2024 guidance, expecting a revenue decline of approximately 3% from the previous year but raised its non-GAAP operating margin guidance to a range of 21% to 21.5% and non-GAAP diluted EPS guidance to $4.05 to $4.15. The company's financial outlook was revised due to the constrained macroeconomic environment, although the demand for Illumina's products remains strong. The company's press release also highlighted the spin-off of GRAIL on June 24, 2024, and several strategic initiatives and product launches aimed at accelerating revenue growth and margin expansion.
全球DNA測序和基於芯片技術的領軍企業illumina於2024年9月29日結束的第三季度於2024年11月4日公佈了其財務業績。公司宣佈Core illumina營業收入在2024年Q3下降到11億美元，較2013年Q3下降2%。儘管營業收入下降，illumina的GAAP營業利潤率顯著增加至68.6%，同期非GAAP營業利潤率爲22.6%。GAAP攤薄後每股收益爲4.03美元，非GAAP攤薄後每股收益爲1.14美元。illumina還調整了對2024財年的指導，預計與上一年相比營業收入下降約3%，但將非GAAP營業利潤率指導提高到21%至21.5%的區間，並將非GAAP攤薄後每股收益指導提高到4.05美元至4.15美元。由於宏觀經濟環境受限，公司的財務展望發生調整，儘管對illumina產品的需求仍然強勁。公司的新聞稿還強調了2024年6月24日GRAIL的分拆，以及幾項旨在加快營收增長和利潤擴張的戰略舉措和產品推出。
全球DNA測序和基於芯片技術的領軍企業illumina於2024年9月29日結束的第三季度於2024年11月4日公佈了其財務業績。公司宣佈Core illumina營業收入在2024年Q3下降到11億美元，較2013年Q3下降2%。儘管營業收入下降，illumina的GAAP營業利潤率顯著增加至68.6%，同期非GAAP營業利潤率爲22.6%。GAAP攤薄後每股收益爲4.03美元，非GAAP攤薄後每股收益爲1.14美元。illumina還調整了對2024財年的指導，預計與上一年相比營業收入下降約3%，但將非GAAP營業利潤率指導提高到21%至21.5%的區間，並將非GAAP攤薄後每股收益指導提高到4.05美元至4.15美元。由於宏觀經濟環境受限，公司的財務展望發生調整，儘管對illumina產品的需求仍然強勁。公司的新聞稿還強調了2024年6月24日GRAIL的分拆，以及幾項旨在加快營收增長和利潤擴張的戰略舉措和產品推出。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間